基于金属有机框架材料的酶固定化策略及药物筛选研究进展

Progress of Enzyme Immobilization Strategies and Drug Screening Based on Metal-Organic Framework Materials

  • 摘要: 酶抑制剂筛选是药物开发的重要途径之一. 酶的三维结构易受到温度、盐浓度等外界因素的干扰,导致其催化活性和稳定性降低,增加了药物筛选成本. 因此,通过酶与载体之间的相互作用对其进行固定化,提高酶结构稳定性,已成为保持酶活力的重要策略. 基于固定化酶从复杂样品中筛选酶抑制剂也成为了药物研发的热点领域. 近年来,金属有机框架材料(metal-organic frameworks, MOFs)因其具有孔径可调、比表面积大、结构简单、环境稳定等特点,被认为是酶固定化的理想载体,为实现酶抑制剂高效筛选提供了新的解决方案. 总结了以MOFs为载体的酶固定化方法及其在抑制剂筛选和应用的相关研究进展,对MOFs酶固定化和药物筛选的机遇和挑战进行了展望.

     

    Abstract: Screening of enzyme inhibitors is one of the important approaches for drug development. The three-dimensional structure of enzymes is susceptible to the interference of external factors such as temperature and salt concentration, leading to a decrease in its catalytic activity and stability and increasing the cost of drug screening. Therefore, immobilization through enzyme-carrier interactions to improve the stability of enzyme structure has become an important strategy to maintain the enzyme activity. Screening enzyme inhibitors from complex samples based on immobilized enzymes has also become a hot field of drug research and development. In recent years, metal-organic frameworks (MOFs) are known as the ideal carrier for enzyme immobilization due to their characteristics of adjustable aperture, large surface area, simple structure, stable environment, and so on, and it provides a novel method to achieve the efficient screening of enzyme inhibitors. The method of enzyme immobilization using MOFs as the carrier, the research progress of inhibitor screening and application were summarized. The opportunities and challenges of MOFs enzyme immobilization and drug screening were prospected.

     

/

返回文章
返回